Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab

Main Article Content

Mark Lebwohl
Andrew Blauvelt
Alan Menter
Kim Papp
Abby Jacobson


psoriasis, brodalumab


Abstract not available.


1. Papp et al. N Engl J Med. 2012;366:1181-1189.

2. Papp et al. J Am Acad Dermatol. 2014;71:1183-1190.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 10 11 12 13 14 15 16 > >>